- Prenetics Global Limited closed its public offering on **October 28, 2025**, generating approximately **$44.0 million** in gross proceeds.  **[1876431_0001628280-25-046720_a6-kx2025x10x28xoffering.htm:0]** **[1876431_0001628280-25-046720_ex9911.htm:0]** 
- The offering included **2,722,642 Class A ordinary shares**, along with Class A and Class B warrants to purchase an equal number of ordinary shares, at a combined price of **$16.08** per share and accompanying warrants.  **[1876431_0001628280-25-046720_a6-kx2025x10x28xoffering.htm:0]** **[1876431_0001628280-25-046720_ex9911.htm:0]** 
- The company plans to use the proceeds for the **global expansion of IM8**, the development and implementation of its **Bitcoin treasury strategy**, working capital, and general corporate purposes.  **[1876431_0001628280-25-046720_a6-kx2025x10x28xoffering.htm:0]** **[1876431_0001628280-25-046720_ex9911.htm:0]** 
- Dominari Securities LLC served as the sole placement agent, receiving an **8% cash success fee** (reduced to **4%** for company-introduced investors) and warrants to purchase **131,829 Ordinary Shares**.  **[1876431_0001628280-25-046720_a6-kx2025x10x28xoffering.htm:0]**

Prenetics Global Limited Closes $44.0 Million Equity Offering

- Prenetics Global Limited announced the successful pricing of a public offering, expecting approximately **$48 million** in gross proceeds from the sale of **2,992,596 Class A ordinary shares** and/or pre-funded warrants at **$16.08** per unit.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:1]**  The offering includes a double warrant structure, potentially yielding up to **$216 million** in total proceeds if all warrants are exercised.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:1]** 
- The capital raise is intended to fuel the global expansion of its IM8 brand and advance its Bitcoin treasury strategy.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:0]** **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:3]**  IM8 achieved **$100 million in annual recurring revenue** within **11 months** of launch and is guided to generate **$160 million to $200 million** in revenue for **2026**.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:0]** **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:3]** 
- Following the offering, Prenetics expects to hold approximately **$100 million in cash** and **275 BTC** (valued at **$31 million** as of October 27, 2025), totaling **$131 million** in liquidity.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:3]** **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:4]**  The company also initiated a strategy to purchase **1 Bitcoin daily** starting August 1, 2025.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:3]** **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:4]** 
- The company is undertaking a strategic review of its other business units with the intention to divest them, aiming to focus resources on the IM8 opportunity and Bitcoin accumulation.  **[1876431_0001628280-25-046342_a6-kx2025x10xsecondpricing.htm:3]**

Prenetics Global Limited Announces Pricing of $48 Million Equity Offering and IM8 Growth

- Prenetics Global Limited announced the successful pricing of a best efforts public offering on **October 27, 2025**, with expected gross proceeds of approximately **$48.0 million**.  **[1876431_0001628280-25-046327_a6-kx2025x10xpricingprxex9.htm:0]** 
- The offering includes **2,992,596 Class A ordinary shares** (or pre-funded warrants) and associated **Class A and Class B Common Warrants**, at a combined offering price of **$16.08 per share** (or pre-funded warrant).  **[1876431_0001628280-25-046327_a6-kx2025x10xpricingprxex9.htm:0]** 
- The proceeds will be used for the **global expansion of IM8** and the **strategic accumulation of Bitcoin (BTC)** as part of the company's pioneering dual-pronged health and wealth strategy.  **[1876431_0001628280-25-046327_a6-kx2025x10xpricingprxex9.htm:0]** 
- The Class A Common Warrants have an exercise price of **$24.12** per Ordinary Share, and the Class B Common Warrants have an exercise price of **$32.16** per Ordinary Share.  **[1876431_0001628280-25-046327_a6-kx2025x10xpricingprxex9.htm:0]** 
- The offering is expected to close on **October 28, 2025**.  **[1876431_0001628280-25-046327_a6-kx2025x10xpricingprxex9.htm:0]**

Prenetics Global Limited Announces $48 Million Equity Offering

- Prenetics Global Limited announced a **proposed public offering** of Class A Ordinary Shares and common warrants on **October 24, 2025**.  **[1876431_0001628280-25-046305_a6-kx2025x10xproposedpubli.htm:0]** **[1876431_0001628280-25-046305_ex991-2025x10x24.htm:0]** 
- The proceeds from the offering will be allocated towards the **global expansion of its IM8 brand** and the **strategic accumulation of Bitcoin (BTC)**.  **[1876431_0001628280-25-046305_ex991-2025x10x24.htm:0]** 
- As of **October 24, 2025**, Prenetics has accumulated a total of **272 BTC** by purchasing 1 Bitcoin per day, establishing itself as the first consumer health company with a Bitcoin treasury.  **[1876431_0001628280-25-046305_ex991-2025x10x24.htm:0]**

Prenetics Global (PRE)